EU Votes to Hasten Generic Pricing, Leaves New Drug Timelines Alone

International Pharmaceutical Regulatory Monitor
A A
The European Parliament voted overwhelmingly in favor of a draft law that would require member states to decide on the pricing and reimbursement of generic medicines within 60 days of an application.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00